Biomark Diagnostics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 6


  • Stock Symbol
  • BUX

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $0.16
  • (As of Tuesday Closing)

Biomark Diagnostics General Information


Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Healthcare Technology Systems
Stock Exchange
Corporate Office
  • 3851 Shell Road
  • Suite 130
  • Richmond, British Columbia V6X 2W2
  • Canada
+1 (604) 000-0000

Biomark Diagnostics Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomark Diagnostics Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.16 $0.16 $0.13 - $0.26 $14.7M 90.9M 26.1K -$0.01

Biomark Diagnostics Financials Summary

In Thousands,
TTM 31-Dec-2023 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021
EV 17,770 13,501 14,985 24,411
Revenue 121 116 35 0
EBITDA (777) (1,016) (976) (813)
Net Income (1,139) (1,391) (1,159) (827)
Total Assets 1,017 541 1,179 755
Total Debt 817 609 841 95
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biomark Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biomark Diagnostics‘s full profile, request access.

Request a free trial

Biomark Diagnostics Executive Team (6)

Name Title Board Seat Contact Info
Rashid Ahmed Founder & Chief Executive Officer
Gina Huang Chief Financial Officer and Project Director
Brian Cheng Chief Technical Officer
Jeff Haince General Manager & Chief Scientific Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Biomark Diagnostics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomark Diagnostics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biomark Diagnostics‘s full profile, request access.

Request a free trial

Biomark Diagnostics Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Luger Minerals 30-Oct-2014 0000000000 Holding Companies
Affinity Research Learning 01-Oct-2014 0000000000 Educational Software
Sierra Coastal Partners 14-Mar-2013 Merger/Acquisition Investment Banks
To view Biomark Diagnostics’s complete acquisitions history, request access »

Biomark Diagnostics FAQs

  • When was Biomark Diagnostics founded?

    Biomark Diagnostics was founded in 2007.

  • Who is the founder of Biomark Diagnostics?

    Rashid Ahmed is the founder of Biomark Diagnostics.

  • Who is the CEO of Biomark Diagnostics?

    Rashid Ahmed is the CEO of Biomark Diagnostics.

  • Where is Biomark Diagnostics headquartered?

    Biomark Diagnostics is headquartered in Richmond, Canada.

  • What is the size of Biomark Diagnostics?

    Biomark Diagnostics has 6 total employees.

  • What industry is Biomark Diagnostics in?

    Biomark Diagnostics’s primary industry is Other Healthcare Technology Systems.

  • Is Biomark Diagnostics a private or public company?

    Biomark Diagnostics is a Public company.

  • What is Biomark Diagnostics’s stock symbol?

    The ticker symbol for Biomark Diagnostics is BUX.

  • What is the current stock price of Biomark Diagnostics?

    As of 28-May-2024 the stock price of Biomark Diagnostics is $0.16.

  • What is the current market cap of Biomark Diagnostics?

    The current market capitalization of Biomark Diagnostics is $14.7M.

  • What is Biomark Diagnostics’s current revenue?

    The trailing twelve month revenue for Biomark Diagnostics is $121K.

  • What is Biomark Diagnostics’s annual earnings per share (EPS)?

    Biomark Diagnostics’s EPS for 12 months was -$0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »